Literature DB >> 23981279

Expert recommendations on the application of interferon for chronic hepatitis B.

Mo Bin Wan1, Xin Hua Weng.   

Abstract

To help the clinicians correctly and scientifically apply interferon for the treatment of chronic hepatitis B, more than 40 experts majored in infectious and liver diseases updated the 'Expert recommendations on the treatment of chronic hepatitis B with interferon (2007)' following a systematic literature review, summary of clinical experiences and thorough consultation and discussion. The updated expert recommendations primarily included fundamental new knowledge of the use of interferon and individualized interferon therapy. Specifically, we provided recommendations for implementing optimized therapeutic regimens based on quantitative changes in hepatitis B surface antigen and hepatitis B virus DNA levels 24 weeks after interferon therapy. The updated expert recommendations provided itemized details and supplement for the Guidelines for the Prevention and Treatment of Chronic Hepatitis B and they also offer a basis for individualized therapy of chronic hepatitis B with interferon.
© 2013 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  chronic hepatitis B; expert recommendation; interferon; optimized therapy; response-guided therapy

Mesh:

Substances:

Year:  2013        PMID: 23981279     DOI: 10.1111/1751-2980.12096

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  2 in total

Review 1.  Optimization therapy for the treatment of chronic hepatitis B.

Authors:  En-Qiang Chen; Hong Tang
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

Review 2.  Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma.

Authors:  Susanne Krammer; Cristina Sicorschi Gutu; Janina C Grund; Mircea T Chiriac; Sabine Zirlik; Susetta Finotto
Journal:  Front Immunol       Date:  2021-11-10       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.